Completed PHASE2/PHASE3 INTERVENTIONAL 4-arm NCT01429987

The Plecanatide Chronic Idiopathic Constipation (CIC) Study

Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation

Sponsor: Bausch Health Americas, Inc.

Conditions Chronic Idiopathic Constipation

Interventions Placebo plecanatide

Updated 11 times since 2017 Last updated: May 23, 2019 Started: Oct 31, 2011 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Chronic Idiopathic Constipation, this trial is completed. The trial is conducted by Bausch Health Americas, Inc. and has accumulated 11 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

11 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2_PHASE3

▶ Show 6 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed PHASE2_PHASE3
Jun 2019 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Aug 2018 — Jun 2019 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Aug 2018 [monthly]

Completed PHASE2_PHASE3
Dec 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Dec 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bausch Health Americas, Inc.
Parexel

Data source: Bausch Health Americas, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Anaheim, United States , Augusta, United States , Baton Rouge, United States , Boone, United States , Boston, United States , Boynton Beach, United States , Brooklyn, United States , Brownsburg, United States , Burbank, United States and 93 more locations